PracSys and NASI clash over linacs

Article

PracSys of Salem, NH, last month entered a claim with the American Arbitration Association against North American Scientific regarding a linear accelerator supply deal between the companies that broke down. PracSys filed the complaint on June 16, after

PracSys of Salem, NH, last month entered a claim with the American Arbitration Association against North American Scientific regarding a linear accelerator supply deal between the companies that broke down. PracSys filed the complaint on June 16, after its attempts to resolve a contract dispute with NASI failed.

PracSys and North American Scientific signed a supply deal last year in which North American agreed to pay PracSys $2.7 million for two linear accelerators (SCAN 3/4/98). North American Scientific planned to use the accelerators to produce palladium-103 for the manufacture of prostate brachytherapy seeds.

But the partnership soured six months ago, according to PracSys. The company’s complaint states that after the agreement with North American Scientific was signed, NASI signed a contract with another vendor for the supply of palladium, and reneged on its obligation to provide a lease guaranty crucial to the PracSys deal. PracSys claims that North American Scientific’s actions prevented it from fulfilling its contract, and the company seeks damages of $3 million.

PracSys’ claim is meritless, North American Scientific executives told SCAN. In a statement also released June 16, the Chatsworth, CA, company declared that it has realized its obligations under the 1998 contract with PracSys, and announced that it has asked PracSys to turn over the uncompleted linear accelerators—for which NASI claims it has paid in full. North American Scientific will install and finish them itself, the company said.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.